News&lnfo
RecBio is a high-tech enterprise jointly founded by the former vaccine R & D expert team from the Chinese Center for Disease Control and Prevention (China CDC) and the senior vaccine industrialization team.
The company has established a leading domestic R & D and innovation platform for new adjuvants, genetic engineering, and immune evaluation.

20201101

  • Categories:企业里程碑
  • Author:
  • Origin:
  • Time of issue:2020-11-01
  • Views:0

(Summary description)In November 2020, RecBio completed Round B financing of more than USD 100 million.

20201101

(Summary description)In November 2020, RecBio completed Round B financing of more than USD 100 million.

  • Categories:企业里程碑
  • Author:
  • Origin:
  • Time of issue:2020-11-01
  • Views:0
Information

In November 2020, RecBio completed Round B financing of more than USD 100 million.

Scan the QR code to read on your phone

Previous: 20200518
Previous: 20200518
  • TOP   

Contact Us

底部联系方式

Time of issue:2022-03-29 08:59:20

Jiangsu Recbio Technology Co., Ltd.

Media Inquiry: media@recbio.cn

Investor Inquiry: ir@recbio.cn

 

Address: Vaccine Engineering Center, China Medical City, Taizhou

Copyright © 2020 Jiangsu Rec-Biotechnology Co., Ltd.  All rights reserved.      苏ICP备19043567号-1